Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Repurchased
Ratios

Resmed (RSMDF) Accumulated Depreciation & Amortization (2016 - 2025)

Historic Accumulated Depreciation & Amortization for Resmed (RSMDF) over the last 16 years, with Q4 2025 value amounting to $49.9 million.

  • Resmed's Accumulated Depreciation & Amortization rose 742.05% to $49.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $49.9 million, marking a year-over-year increase of 742.05%. This contributed to the annual value of $198.5 million for FY2025, which is 1221.41% up from last year.
  • Latest data reveals that Resmed reported Accumulated Depreciation & Amortization of $49.9 million as of Q4 2025, which was up 742.05% from $47.7 million recorded in Q3 2025.
  • Resmed's 5-year Accumulated Depreciation & Amortization high stood at $198.5 million for Q2 2025, and its period low was $36.3 million during Q3 2022.
  • In the last 5 years, Resmed's Accumulated Depreciation & Amortization had a median value of $44.8 million in 2023 and averaged $75.2 million.
  • As far as peak fluctuations go, Resmed's Accumulated Depreciation & Amortization plummeted by 9327.82% in 2021, and later soared by 2387.73% in 2023.
  • Quarter analysis of 5 years shows Resmed's Accumulated Depreciation & Amortization stood at $40.8 million in 2021, then dropped by 7.41% to $37.8 million in 2022, then increased by 18.58% to $44.8 million in 2023, then grew by 3.7% to $46.4 million in 2024, then rose by 7.42% to $49.9 million in 2025.
  • Its Accumulated Depreciation & Amortization stands at $49.9 million for Q4 2025, versus $47.7 million for Q3 2025 and $198.5 million for Q2 2025.